Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...
AI. Is there reason to worry? A new experiment tests how gen-AI imagery can affect how people feel about their bodies.
Cancer research has rapidly entered a data-rich era. Today, researchers can draw on whole-genome sequencing, single-cell atlases, longitudinal liquid biopsy ...
A comprehensive review recently published in Current Molecular Pharmacology (2026, Volume 19, Pages 85–96) examines the ...
Artificial intelligence (AI) is increasingly reshaping diagnostic pathology, with breast pathology representing one of the most advanced and clinically impactful areas of adoption.
AI‑guided analysis surfaces a new CAR T target with multi‑cancer activity, as Penn researchers validate GPNMB‑directed CAR T cells in preclinical models.
Recent advances in subcellular imaging transcriptomics platforms have enabled spatial mapping of the expression of hundreds of genes at subcellular resolution and provide topographic context to the ...
This repository was used to develop Mirai, the risk model described in: Towards Robust Mammography-Based Models for Breast Cancer Risk. Mirai was designed to predict risk at multiple time points, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results